Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin

By sjmartinez • June 28, 2023

Bae SS, Faure-Kumar E, Ferbas K, Wang J, Shahbazian A, Truong L, Yang H, McMahon M, FitzGerald JD, Charles-Schoeman C. Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin. Rheumatol Int. 2023 Jun 27. doi: 10.1007/s00296-023-05350-1. Epub ahead of print. PMID: 37368037.

Tags: Anti-SARS-CoV2 antibodies, Dermatomyositis, Digestive Diseases, Idiopathic inflammatory myopathies, Intravenous immunoglobulin, Polymyositis, Publications, Rheumatology

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis

Singh S, Murad MH, Yuan Y, Ananthakrishnan AN, Click B, Syal G, Haydek JP, Agrawal M, Kappelman MD, Lewis JD, Scott FI. Comparative Efficacy of[...]

Chang A, Oh J, Shin A, Oser M, Manitius N, Ghaffari A, Limketkai BN. Similar Symptoms, Distinct Syndromes: Multi-modal Approach to the Patient with an[...]

Perspective on alcohol-induced organ damage via autophagy-dependent cellular changes

Bakheet A, Anbazhagan M, Barve S, Dasarathy S, Dickinson JJ, Ding WX, Donohue TM Jr, Gopal T, Gukovskaya A, Kharbanda KK, Lemasters JJ, Osna NA,[...]